Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT02849431
Other study ID # 16/EM/0100
Secondary ID
Status Withdrawn
Phase N/A
First received July 11, 2016
Last updated August 24, 2016
Start date July 2016
Est. completion date August 2016

Study information

Verified date July 2016
Source Canterbury Christ Church University
Contact n/a
Is FDA regulated No
Health authority United Kingdom: National Health ServiceUnited Kingdom: Research Ethics Committee
Study type Interventional

Clinical Trial Summary

This study explores the feasibility of a mindfulness-based intervention for people with a diagnosis of borderline personality disorder.


Description:

This is an uncontrolled feasibility trial of an eight-week mindfulness-based intervention for people with a diagnosis of borderline personality disorder. A battery of measures will be administered at baseline, in a time window of six to zero weeks prior to the start of the intervention. Outcome measures will be repeated in the two weeks after the end of the eight-week intervention, along with a qualitative interview.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date August 2016
Est. primary completion date August 2016
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion criteria:

- Are on the caseload of a United Kingdom National Health Service Assessment and Treatment Service in the recruitment area and have had contact with that service in the past three months

- Have received the diagnosis of Borderline Personality Disorder from a suitably qualified health care professional, and continue to meet criteria for this diagnosis according to the SCID-II (Structured Clinical Interview for DSM Disorders Version II) at their screening assessment

- Have sufficient English language speaking and comprehension abilities to access group discussions and hand-out materials

- Have not previously engaged in a mindfulness-based intervention. As in other similar trials, a minimum dose has been operationally defined as having undertaken 50% or more of a mindfulness-based intervention delivered face-to-face by a suitably qualified health care professional

- Are not currently receiving, nor have plans to receive any other form of psychological therapy during the course of the study

Exclusion criteria:

- Have psychosis

- Misuse alcohol or drug to a level that requiring detox

- Have a intellectual disability

- Present a high level of risk requiring inpatient management at the time of their screening assessment

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
Mindfulness-based intervention
A version of mindfulness-based cognitive therapy that has been adapted for people with a diagnosis of borderline personality disorder. This comprises eight weekly session, each lasting ninety minutes.

Locations

Country Name City State
United Kingdom Sussex Partnership NHS Foundation Trust Brighton Sussex

Sponsors (2)

Lead Sponsor Collaborator
Canterbury Christ Church University Sussex Partnership NHS Foundation Trust

Country where clinical trial is conducted

United Kingdom, 

References & Publications (1)

Elliot R. (2012). Qualitative Methods for Studying Psychotherapy Change Processes. In: Thompson, A, & Harper D. (Eds.), Qualitative research methods in mental health and psychotherapy: An introduction for students and practitioners (pp. 69-81). Chichester, UK: Wiley-Blackwells

Outcome

Type Measure Description Time frame Safety issue
Primary Participant retention in percent The number of participants who remain in the study at the post-intervention time point divided by the number of participants who are recruited into the study at baseline, expressed as a percentage At post-intervention (i.e. 8 weeks after the start of the intervention). No
Secondary Change from baseline at post-intervention in the Difficulties in the Emotion Regulation Scale (DERS) Post-intervention (i.e. 8 weeks after the start of the intervention) No
Secondary Change from baseline at post-intervention in the Patient Health Questionnaire (PQH-9). Post-intervention (i.e. 8 weeks after the start of the intervention) No
Secondary Change from baseline at post-intervention in the Generalized Anxiety Disorder Scale (GAD-7) Post-intervention (i.e. 8 weeks after the start of the intervention) No
Secondary Change from baseline at post-intervention in the Five-Facet Mindfulness Questionnaire (FFMQ) Post-intervention (i.e. 8 weeks after the start of the intervention) No
Secondary United Kingdom National Health Service Friends and Family Test (FFT). Post-intervention (i.e. 8 weeks after the start of the intervention) No
Secondary Elliot et al.'s (2001) Change Interview. Post-intervention (i.e. 8 weeks after the start of the intervention) No
Secondary Recruitment rate The number of participants recruited into the study at baseline divided by the time taken to recruit these participants, measured from the date at which recruitment opened. Baseline No
Secondary Qualitative feedback from participants on intervention acceptability in response to questions 6 and 7 of Elliot et al.'s (2001) Change Interview Post-intervention (i.e. 8 weeks after the start of the intervention) No
See also
  Status Clinical Trial Phase
Recruiting NCT04856449 - DBT Skills Plus EMDR for BPD and Trauma N/A
Active, not recruiting NCT04587518 - Five Factor Model Treatment for Borderline Personality Disorder N/A
Recruiting NCT05651295 - A Precision Medicine Approach to Target Engagement for Emotion Regulation N/A
Completed NCT03677037 - The Short-Term MBT Project Phase 3
Not yet recruiting NCT05989529 - Delving Into Borderline Personality Disorder Clinical Trial Experiences
Completed NCT02068326 - MBT in Groups for Adolescents With BPD or Subthreshold BPD Versus TAU - the M-GAB Randomized Controlled Trial N/A
Completed NCT02518906 - Evaluation of AIT Study N/A
Recruiting NCT04296604 - Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations N/A
Completed NCT02108990 - Acetaminophen and Social Processes Phase 2
Terminated NCT02149823 - Examining Dose-Related Effects of Oxytocin on Social Cognition Across Populations Phase 1
Completed NCT02988037 - Adapted Dialectical Behaviour Therapy for Adolescents With Deliberate Self-Harm: A Pre-post Observational Study N/A
Not yet recruiting NCT01683136 - Evaluation of the HBDL Coil Transcranial Magnetic Stimulation (TMS) Device - Feasibility Study for the Treatment of Borderline Personality Disorder N/A
Completed NCT01635556 - Evaluation of a Modified Dialectical Behavior Therapy Program N/A
Completed NCT02397031 - Mindfulness and Interpersonal Effectiveness Skills in Borderline Personality Disorder N/A
Terminated NCT01103180 - Selective Serotonin Reuptake Inhibitors (SSRIs) in Borderline Personality Disorder Phase 2
Terminated NCT01212588 - Preliminary Trial of the Effect of Glucocorticoid Receptor Antagonist on Borderline Personality Disorder (BPD) Phase 2
Terminated NCT00539188 - N-Acetylcysteine in Adjunct to DBT for the Treatment of Self-Injurious Behavior in BPD Phase 2
Recruiting NCT05398627 - Neurofeedback for Borderline Personality Disorder N/A
Recruiting NCT03994510 - SHame prOpensity in bOrderline Personality Disorder N/A
Recruiting NCT06005129 - Personality Change Study for Borderline Personality Disorder N/A